account_id none on file
legal_name Halozyme Therapeutics, Inc.
ticker HALO
cik 1159036
domain halozyme.com
linkedin_company_url https://www.linkedin.com/company/halozyme-therapeutics-inc-/jobs/
entry_point_account_id none on file
name Halozyme Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq San Diego, CA, United States
sector index/company/sector/health-care/
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
~$100M est. in sales in 2023; ~$25M in sales/year
ir_statement / Sep 15, 2026 / receipt
25% CAGR next 5 years
ir_statement / Sep 15, 2026 / receipt
Breakeven achieved in 2023
ir_statement / Sep 15, 2026 / receipt
Raising 2026 Financial Guidance
ir_statement / Sep 15, 2026 / receipt
executivesnone on file
familynone on file
upcoming
changes
| 2021-12-13 | Senior Vice President, departed | sec_8k |
mcp_package_hint
slug halozyme-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$